Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CPA3 | P15088 | 3/20 | 0.46 |
| ▸ | CPA1 | P15085 | 2/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | CPB1 | P15086 | 1/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4842827 | 1.00 | ALPI (0.53) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL839468 | 1.00 | ALPI (0.53) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL9395387 | 0.95 | PKM (0.49) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL9395382 | 0.95 | ALPI (0.49) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL9230062 | 0.90 | SRR (0.50) | CPA1SRRPPARGPPARA | |
| SCHEMBL6088591 | 0.86 | EPHX1 (0.50) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL7394752 | 0.86 | ALPI (0.46) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL7682382 | 0.86 | ALPI (0.46) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL8882105 | 0.84 | PPARA (0.45) | MEN1KMT2ACPA1PPARGPPARA | |
| SCHEMBL8695322 | 0.84 | PPARG (0.47) | MEN1KMT2AMAPTNPSR1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1487836-B1 | ETHANE-1,2-DIAMINO-BIS (2R)-2-BROMO-3-PHENYLPROPANOATE|, METHOD FOR PRODUCTION AND USE THEREOF | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-09-06 | — | — | EP | claimed |
| US-7009047-B2 | Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-03-07 | — | — | US | claimed |
| EP-1487836-A1 | ETHANE-1,2-DIAMINO-BIS (2R)-2-BROMO-3-PHENYLPROPANOATE], METHOD FOR PRODUCTION AND USE THEREOF | Aventis Pharma Deutschland GmbH (DE) | 2004-12-22 | — | — | EP | claimed |
| EP-1138671-B1 | Production method of aromatic acylthiocarboxylic acid derivative | AJINOMOTO KK (JP) | 2004-09-01 | — | — | EP | claimed |
| US-20040010039-A1 | Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use | DEUTSCHE BANK AG NEW YORK BRANCH | 2004-01-15 | — | — | US | claimed |
| WO-2003078434-A1 | ETHANE-1,2-DIAMINO-BIS[(2R)-2-BROMO-3-PHENYLPROPANOATE], METHOD FOR PRODUCTION AND USE THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-09-25 | — | — | WO | claimed |
| US-20030125575-A1 | Process for the preparation of(R)-2-bromo-3-phenyl -propionic acid | DSM N.V. (NL) | 2003-07-03 | — | — | US | claimed |
| US-20030120102-A1 | Method for the preparation of (s) -2-acetylthio-3-phenylpropionic acid | DSM IP ASSETS B.V. (NL) | 2003-06-26 | — | — | US | claimed |
| EP-1272466-A1 | METHOD FOR THE PREPARATION OF (S)-2-ACETYLTHIO-3-PHENYLPROPIONIC ACID | DSM N.V. (NL) | 2003-01-08 | — | — | EP | claimed |
| EP-1272452-A2 | PROCESS FOR THE PREPARATION OF (R)-2-BROMO-3-PHENYL-PROPIONIC ACID | DSM N.V. (NL) | 2003-01-08 | — | — | EP | claimed |
| US-6482978-B2 | REACTING AN AROMATIC AMINO ACID WITH SODIUM NITRIDE AND HYDROGEN BOMIDE; FORMING AROMATIC BROMOCARBOXYLIC ACID CHEMICAL INTERMEDIATE | AJINOMOTO CO., INC. (JP) | 2002-11-19 | — | — | US | claimed |
| EP-1056715-B1 | PROCESS FOR PREPARING 2-ACETYLTHIO-3-PHENYL-PROPIONIC ACID AND THE SALTS THEREOF | ZAMBON SPA (IT) | 2002-06-12 | — | — | EP | claimed |
| US-20020010358-A1 | Production method of aromatic carboxylic acid derivative | AJINOMOTO CO., INC. (JP) | 2002-01-24 | — | — | US | claimed |
| EP-1138671-A1 | Production method of aromatic acylthiocarboxylic acid derivative | Ajinomoto Co., Inc. (JP) | 2001-10-04 | — | — | EP | claimed |
| WO-2001058837-A2 | PROCESS FOR THE PREPARATION OF (R)-2-BROMO-3-PHENYL-PROPIONIC ACID | DSM N.V. (NL) | 2001-08-16 | — | — | WO | claimed |
| WO-2001058865-A1 | METHOD FOR THE PREPARATION OF (S)-2-ACETYLTHIO-3-PHENYLPROPIONIC ACID | DSM N.V. (NL) | 2001-08-16 | — | — | WO | claimed |
| EP-1056715-A1 | PROCESS FOR PREPARING 2-ACETYLTHIO-3-PHENYL-PROPIONIC ACID AND THE SALTS THEREOF | ZAMBON GROUP S.p.A. (IT) | 2000-12-06 | — | — | EP | claimed |
| US-6080881-A | Process for preparing 2-acetythio-3-phenyl-propionic acid and the salts thereof | ZAMBON GROUP S.P.A. (IT) | 2000-06-27 | — | — | US | claimed |
| WO-1999042438-A1 | PROCESS FOR PREPARING 2-ACETYLTHIO-3-PHENYL-PROPIONIC ACID AND THE SALTS THEREOF | ZAMBON GROUP S.P.A. (IT) | 1999-08-26 | — | — | WO | claimed |
| EP-4619408-A1 | THE SYNTHESIS OF OMAPATRILAT | Endothelium Scanning Nanotechnology Limited (AU) | 2025-09-24 | — | — | EP | disclosed |
| WO-2024103123-A1 | THE SYNTHESIS OF OMAPATRILAT | Endothelium Scanning Nanotechnology Limited (AU) | 2024-05-23 | — | — | WO | disclosed |
| US-20150011597-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE BIOPHARMA R&D IP, LLC. (US) | 2015-01-08 | — | — | US | disclosed |
| US-8735625-B2 | Dual-acting antihypertensive agents | THERAVANCE, INC. (US) | 2014-05-27 | — | — | US | disclosed |
| US-20140046075-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| US-8394846-B2 | Dual-acting antihypertensive agents | THERAVANCE, INC. (US) | 2013-03-12 | — | — | US | disclosed |
| US-20120129900-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2012-05-24 | — | — | US | disclosed |
| US-8143298-B2 | Dual-acting antihypertensive agents | THERAVANCE, INC. (US) | 2012-03-27 | — | — | US | disclosed |
| US-20100267788-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-7803586-B2 | Chemical Process | ASTRAZENECA AB (SE) | 2010-09-28 | — | — | US | disclosed |
| US-7777077-B2 | 2-Mercaptomethyl-4-methylpentanoic Acid (2-Butyryl-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]aminoethyl)amide | THERAVANCE, INC. (US) | 2010-08-17 | — | — | US | disclosed |
| US-20080188533-A1 | 2-Mercaptomethyl-4-methylpentanoic Acid (2-Butyryl-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]aminoethyl)amide | THERAVANCE BIOPHARMA R&D IP, LLC | 2008-08-07 | — | — | US | disclosed |
| US-7388098-B2 | Dynamic resolution of isomers and resolved isomers | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-06-17 | — | — | US | disclosed |
| US-7388098-B2 | Dynamic resolution of isomers and resolved isomers | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-06-17 | — | — | US | disclosed |
| US-20080115247-A1 | Chemical Process | ASTRAZENECA AB (SE) | 2008-05-15 | — | — | US | disclosed |
| CN-101080495-A | Chemical process | ASTRAZENECA AB (SE) | 2007-11-28 | — | — | CN | disclosed |
| EP-1828394-A2 | CHEMICAL PROCESS | AstraZeneca AB (SE) | 2007-09-05 | — | — | EP | disclosed |
| US-7141694-B2 | Enzymatic resolution of aryl and thio-substituted acids | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-11-28 | — | — | US | disclosed |
| US-20060247470-A1 | Process for producing optically active carboxylic acid substituted in 2-position | KANEKA CORPORATION | 2006-11-02 | — | — | US | disclosed |
| EP-1487836-B1 | ETHANE-1,2-DIAMINO-BIS (2R)-2-BROMO-3-PHENYLPROPANOATE|, METHOD FOR PRODUCTION AND USE THEREOF | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-09-06 | — | — | EP | disclosed |
| US-7094926-B2 | Process for producing optically active carboxylic acid substituted in 2-position | KANEKA CORPORATION (JP) | 2006-08-22 | — | — | US | disclosed |
| WO-2006064213-A2 | CHEMICAL PROCESS | ASTRAZENECA AB (SE) | 2006-06-22 | — | — | WO | disclosed |
| US-7026143-B2 | Enzymatic resolution of aryl and thio-substituted acids | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-04-11 | — | — | US | disclosed |
| US-7009047-B2 | Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-03-07 | — | — | US | disclosed |
| EP-1324975-B1 | DYNAMIC RESOLUTION OF ISOMERS AND RESOLVED ISOMERS | BRISTOL MYERS SQUIBB CO (US) | 2005-11-16 | — | — | EP | disclosed |
| US-20050245764-A1 | Process for producing optically active 2-substituted carboxylic acid | KANEKA CORPORATION (JP) | 2005-11-03 | — | — | US | disclosed |
| EP-1487836-A1 | ETHANE-1,2-DIAMINO-BIS (2R)-2-BROMO-3-PHENYLPROPANOATE], METHOD FOR PRODUCTION AND USE THEREOF | Aventis Pharma Deutschland GmbH (DE) | 2004-12-22 | — | — | EP | disclosed |
| EP-1138671-B1 | Production method of aromatic acylthiocarboxylic acid derivative | AJINOMOTO KK (JP) | 2004-09-01 | — | — | EP | disclosed |
| EP-1422215-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-SUBSTITUTED CARBOXYLIC ACID | KANEKA CORPORATION (JP) | 2004-05-26 | — | — | EP | disclosed |
| EP-0629627-B1 | Bicyclic carboxylic acids and their derivatives as nep and aca inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2004-05-06 | — | — | EP | disclosed |
| US-20040077061-A1 | Enzymatic resolution of aryl and thio-substituted acids | ZHU JINGYANG (US) | 2004-04-22 | — | — | US | disclosed |
| US-20040069208-A1 | Process for crystallizing enantiomerically enriched 2-acetylthio-3-phenylpropionic acid | DSM IP ASSETS B.V. (NL) | 2004-04-15 | — | — | US | disclosed |
| US-20040072310-A1 | Enzymatic resolution of aryl and thio-substituted acids | ZHU JINGYANG (US) | 2004-04-15 | — | — | US | disclosed |
| US-20040010039-A1 | Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use | DEUTSCHE BANK AG NEW YORK BRANCH | 2004-01-15 | — | — | US | disclosed |
| WO-2003104189-A2 | COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003078434-A1 | ETHANE-1,2-DIAMINO-BIS[(2R)-2-BROMO-3-PHENYLPROPANOATE], METHOD FOR PRODUCTION AND USE THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-09-25 | — | — | WO | disclosed |
| US-6620600-B2 | Monitoring preferential compounds in racemic; obtain enantiomer, incubate with racemic mix, hydrolyze mix, recover preferential compound | BRISTOL-MYERS SQUIBB CO. | 2003-09-16 | — | — | US | disclosed |
| US-20030144546-A1 | Process for producing optically active carboxylic acid subtituted in 2-position | KANEKA CORPORATION (JP) | 2003-07-31 | — | — | US | disclosed |
| EP-1328655-A2 | ENZYMATIC RESOLUTION OF ARYL- AND THIO-SUBSTITUTED ACIDS | Bristol-Myers Squibb Company (US) | 2003-07-23 | — | — | EP | disclosed |
| EP-1324975-A2 | DYNAMIC RESOLUTION OF ISOMERS AND RESOLVED ISOMERS | Bristol-Myers Squibb Company (US) | 2003-07-09 | — | — | EP | disclosed |
| US-20030125575-A1 | Process for the preparation of(R)-2-bromo-3-phenyl -propionic acid | DSM N.V. (NL) | 2003-07-03 | — | — | US | disclosed |
| US-20030125575-A1 | Process for the preparation of(R)-2-bromo-3-phenyl -propionic acid | DSM N.V. (NL) | 2003-07-03 | — | — | US | disclosed |
| US-20030120102-A1 | Method for the preparation of (s) -2-acetylthio-3-phenylpropionic acid | DSM IP ASSETS B.V. (NL) | 2003-06-26 | — | — | US | disclosed |
| US-20030120102-A1 | Method for the preparation of (s) -2-acetylthio-3-phenylpropionic acid | DSM IP ASSETS B.V. (NL) | 2003-06-26 | — | — | US | disclosed |
| US-20030120102-A1 | Method for the preparation of (s) -2-acetylthio-3-phenylpropionic acid | DSM IP ASSETS B.V. (NL) | 2003-06-26 | — | — | US | disclosed |
| CN-1425001-A | Process for preparing -2-acetylthio-3-phenylpropionic acid | DSM NV (NL) | 2003-06-18 | — | — | CN | disclosed |
| CN-1425001-A | Process for preparing -2-acetylthio-3-phenylpropionic acid | DSM NV (NL) | 2003-06-18 | — | — | CN | disclosed |
| EP-1313702-A1 | PROCESS FOR CRYSTALLIZING ENANTIOMERICALLY ENRICHED 2-ACETYLTHIO-3-PHENYLPROPIONIC ACID | DSM N.V. (NL) | 2003-05-28 | — | — | EP | disclosed |
| EP-0728746-B1 | Azepinone compounds useful in the inhibition of ACE and NEP | BRISTOL MYERS SQUIBB CO (US) | 2003-05-28 | — | — | EP | disclosed |
| CN-1416414-A | Process for preparing -2-bromo-3-phenylpropionic acid | DSM NV (NL) | 2003-05-07 | — | — | CN | disclosed |
| US-20030013903-A1 | Process for crystallization of 2-acetylthio-3-phenyl-propionic acid | KANEKA CORPORATION (JP) | 2003-01-16 | — | — | US | disclosed |
| EP-1275642-A1 | PROCESS FOR CRYSTALLIZATION OF 2-ACETYLTHIO-3-PHENYL-PROPIONIC ACID | KANEKA CORPORATION (JP) | 2003-01-15 | — | — | EP | disclosed |
| EP-1272466-A1 | METHOD FOR THE PREPARATION OF (S)-2-ACETYLTHIO-3-PHENYLPROPIONIC ACID | DSM N.V. (NL) | 2003-01-08 | — | — | EP | disclosed |
| EP-1272452-A2 | PROCESS FOR THE PREPARATION OF (R)-2-BROMO-3-PHENYL-PROPIONIC ACID | DSM N.V. (NL) | 2003-01-08 | — | — | EP | disclosed |
| EP-1272452-A2 | PROCESS FOR THE PREPARATION OF (R)-2-BROMO-3-PHENYL-PROPIONIC ACID | DSM N.V. (NL) | 2003-01-08 | — | — | EP | disclosed |
| EP-1272466-A1 | METHOD FOR THE PREPARATION OF (S)-2-ACETYLTHIO-3-PHENYLPROPIONIC ACID | DSM N.V. (NL) | 2003-01-08 | — | — | EP | disclosed |
| US-6482978-B2 | REACTING AN AROMATIC AMINO ACID WITH SODIUM NITRIDE AND HYDROGEN BOMIDE; FORMING AROMATIC BROMOCARBOXYLIC ACID CHEMICAL INTERMEDIATE | AJINOMOTO CO., INC. (JP) | 2002-11-19 | — | — | US | disclosed |
| EP-1251115-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE CARBOXYLIC ACID SUBSTITUTED IN 2-POSITION | KANEKA CORPORATION (JP) | 2002-10-23 | — | — | EP | disclosed |
| US-20020111512-A1 | Dynamic resolution of isomers and resolved isomers | BRISTOL-MYERS SQUIBB COMPANY | 2002-08-15 | — | — | US | disclosed |
| EP-1056715-B1 | PROCESS FOR PREPARING 2-ACETYLTHIO-3-PHENYL-PROPIONIC ACID AND THE SALTS THEREOF | ZAMBON SPA (IT) | 2002-06-12 | — | — | EP | disclosed |
| US-20020061565-A1 | Monitoring preferential compounds in racemic; obtain enantiomer, incubate with racemic mix, hydrolyze mix, recover preferential compound | BRISTOL-MYERS SQUIBB COMPANY | 2002-05-23 | — | — | US | disclosed |
| WO-2002028809-A2 | DYNAMIC RESOLUTION OF ISOMERS AND RESOLVED ISOMERS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-04-11 | — | — | WO | disclosed |
| WO-2002022849-A2 | ENZYMATIC RESOLUTION OF ARYL- AND THIO-SUBSTITUTED ACIDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-03-21 | — | — | WO | disclosed |
| WO-2001058837-A3 | PROCESS FOR THE PREPARATION OF (R)-2-BROMO-3-PHENYL-PROPIONIC ACID | DSM NV (NL) | 2002-02-28 | — | — | WO | disclosed |
| WO-2002006217-A1 | PROCESS FOR CRYSTALLIZING ENANTIOMERICALLY ENRICHED 2-ACETYLTHIO-3-PHENYLPROPIONIC ACID | DSM N.V. (NL) | 2002-01-24 | — | — | WO | disclosed |
| US-20020010358-A1 | Production method of aromatic carboxylic acid derivative | AJINOMOTO CO., INC. (JP) | 2002-01-24 | — | — | US | disclosed |
| EP-1138671-A1 | Production method of aromatic acylthiocarboxylic acid derivative | Ajinomoto Co., Inc. (JP) | 2001-10-04 | — | — | EP | disclosed |
| WO-2001058837-A2 | PROCESS FOR THE PREPARATION OF (R)-2-BROMO-3-PHENYL-PROPIONIC ACID | DSM N.V. (NL) | 2001-08-16 | — | — | WO | disclosed |
| WO-2001058837-A2 | PROCESS FOR THE PREPARATION OF (R)-2-BROMO-3-PHENYL-PROPIONIC ACID | DSM N.V. (NL) | 2001-08-16 | — | — | WO | disclosed |
| WO-2001058865-A1 | METHOD FOR THE PREPARATION OF (S)-2-ACETYLTHIO-3-PHENYLPROPIONIC ACID | DSM N.V. (NL) | 2001-08-16 | — | — | WO | disclosed |
| WO-2001058865-A1 | METHOD FOR THE PREPARATION OF (S)-2-ACETYLTHIO-3-PHENYLPROPIONIC ACID | DSM N.V. (NL) | 2001-08-16 | — | — | WO | disclosed |
| US-6235922-B1 | COUPLING BY AMIDATION | BRISTOL-MYERS SQUIBB CO. | 2001-05-22 | — | — | US | disclosed |
| EP-1056715-A1 | PROCESS FOR PREPARING 2-ACETYLTHIO-3-PHENYL-PROPIONIC ACID AND THE SALTS THEREOF | ZAMBON GROUP S.p.A. (IT) | 2000-12-06 | — | — | EP | disclosed |
| US-6143886-A | CYCLOPROPYL-SUBSTITUTED AZEPINONE COMPOUNDS WHICH ARE USEFUL EITHER AS SELECTIVE ANGIOTENSIN CONVERTING ENZYME INHIBITORS, OR AS DUAL INHIBITORS OF BOTH ANGIOTENSIN CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE | BRISTOL-MYERS SQUIBB CO. (US) | 2000-11-07 | — | — | US | disclosed |
| JP-2000309557-A | PRODUCTION OF OPTICALLY ACTIVE PROPIONIC ACID DERIVATIVE | AJINOMOTO CO INC | 2000-11-07 | — | — | JP | disclosed |
| EP-0747392-B1 | 1,2-Diazepine containing dual action inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2000-11-02 | — | — | EP | disclosed |
| CN-1058013-C | Prep of novel mercaptoacetylamide derivatives | MERRELL DOW PHARMA (US) | 2000-11-01 | — | — | CN | disclosed |
| EP-0743319-B1 | Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep | BRISTOL MYERS SQUIBB CO (US) | 2000-09-06 | — | — | EP | disclosed |
| US-6080881-A | Process for preparing 2-acetythio-3-phenyl-propionic acid and the salts thereof | ZAMBON GROUP S.P.A. (IT) | 2000-06-27 | — | — | US | disclosed |
| EP-0728144-B1 | PEPTIDYL COMPOUNDS AND THEIR THERAPEUTIC USE AS INHIBITORS OF METALLOPROTEINASES | DARWIN DISCOVERY LTD (GB) | 2000-01-19 | — | — | EP | disclosed |
| US-5994537-A | Process for preparing azepinone compounds useful in the inhibition of ACE and NEP | BRISTOL-MYERS SQUIBB CO. (US) | 1999-11-30 | — | — | US | disclosed |
| CN-1046525-C | Compounds containing a fused bicyclic ring and processes therefor | BRISTOL MYERS SQUIBB CO (US) | 1999-11-17 | — | — | CN | disclosed |
| WO-1999042438-A1 | PROCESS FOR PREPARING 2-ACETYLTHIO-3-PHENYL-PROPIONIC ACID AND THE SALTS THEREOF | ZAMBON GROUP S.P.A. (IT) | 1999-08-26 | — | — | WO | disclosed |
| US-5877313-A | ANGIOTENSIN CONVERTING ENZYME INHIBITOR | BRISTOL-MYERS SQUIBB (US) | 1999-03-02 | — | — | US | disclosed |
| US-5853623-A | Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases | CHIROSCIENCE LIMITED (GB) | 1998-12-29 | — | — | US | disclosed |
| US-5801274-A | N- mercaptoacyl(amino acid or peptide)! compounds and S-lipophilic aliphatic carbonyl derivatives thereof as antihypertensives | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 1998-09-01 | — | — | US | disclosed |
| CN-1039008-C | Dual action inhibitors | SQUIBB & SONS INC (US) | 1998-07-08 | — | — | CN | disclosed |
| US-5756832-A | REACTING AN ALDHYDE WITH AN ORTHOFORMATE IN THE PRESENCE OF AN ACID CATALYST AND AN ALCOHOL | BRISTOL-MYERS SQUIBB CO. (US) | 1998-05-26 | — | — | US | disclosed |
| US-5750687-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS, NEUTRAL ENDOPEPTIDASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| EP-0481522-B1 | Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace | MERRELL PHARMA INC (US) | 1997-12-29 | — | — | EP | disclosed |
| CN-1166490-A | Prep of novel mercaptoacetylamide derivatives | MERRELL DOW PHARMA (US) | 1997-12-03 | — | — | CN | disclosed |
| CN-1036590-C | Process for preparing mercaptoacetylamide derivatives | MERRELL DOW PHARMA (US) | 1997-12-03 | — | — | CN | disclosed |
| US-5679671-A | ANGIOTENSIN 1-CONVERTING ENZYME INHIBITOR, VASOPRESSIN ANTAGONISM AND ATRIAL NAUTRIURETIC PEPTIDE HYDROLASE INHIBITOR | EISAI CO., LTD. (JP) | 1997-10-21 | — | — | US | disclosed |
| US-5672599-A | DUAL ACTION ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND NEUTRAL ENDOPEPTIDASE INHIBITORS; TREATMENT OF CARDIOVASCULAR DISORDERS | BRISTOL-MYERS SQUIBB CO. (US) | 1997-09-30 | — | — | US | disclosed |
| US-5670699-A | Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring | BRISTOL-MYERS SQUIBB CO. (US) | 1997-09-23 | — | — | US | disclosed |
| US-5635504-A | Diazepine containing dual action inhibitors | BRISTOL-MYERS SQUIBB CO. (US) | 1997-06-03 | — | — | US | disclosed |
| US-5627278-A | MULTISTAGE REACTION FORMED BY AMIDATION, COUPLING AND REDUCTION | BRISTOL-MYERS SQUIBB CO. (US) | 1997-05-06 | — | — | US | disclosed |
| US-5616775-A | ESTERIFYING A N-PROTECTED METHIONINE; OXIDIZING; REACTING WITH AN ACID ANHYDRIDE THEN AN ALKALI METAL HYDROXIDE | BRISTOL-MYERS SQUIBB CO. (US) | 1997-04-01 | — | — | US | disclosed |
| US-5591891-A | PEPTIDASE INHIBITORS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1997-01-07 | — | — | US | disclosed |
| US-5587375-A | TREATING BLOOD PRESSURE, INTRAOCULAR PRESSURE, CARDIOVASCULAR DISORDERS, GLAUCOMA, AND RENAL DISEASES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-24 | — | — | US | disclosed |
| EP-0747392-A1 | 1,2-Diazepine containing dual action inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-11 | — | — | EP | disclosed |
| EP-0743319-A1 | Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-11-20 | — | — | EP | disclosed |
| EP-0728746-A1 | Azepinone compounds useful in the inhibition of ACE and NEP | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-08-28 | — | — | EP | disclosed |
| US-5527795-A | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace | MERRELL PHARMACEUTICALS INC. (US) | 1996-06-18 | — | — | US | disclosed |
| US-5508272-A | SELECTIVE ACE INHIBITORS, HYPOTENSIVE AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-04-16 | — | — | US | disclosed |
| US-5496805-A | DIURETIC, HYPOTENSIVE | E. R. SQUIBB & SONS, INC. (US) | 1996-03-05 | — | — | US | disclosed |
| US-5491143-A | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE | MERRELL DOW PHARMACEUTICALS INC. (US) | 1996-02-13 | — | — | US | disclosed |
| EP-0671172-A1 | AMINO ACID DERIVATIVE | Eisai Co., Ltd. (JP) | 1995-09-13 | — | — | EP | disclosed |
| US-5430145-A | Analgesics, reduction of drug withdrawal symptoms, hypotensive agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1995-07-04 | — | — | US | disclosed |
| CN-1099392-A | Compounds containing a fused bicyclic ring and processes therefor | BRISTOL MYERS SQIBB COMPANY (US) | 1995-03-01 | — | — | CN | disclosed |
| EP-0629627-A2 | Bicyclic carboxylic acids and their derivatives as nep and aca inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-12-21 | — | — | EP | disclosed |
| WO-1994026719-A1 | MERCAPTO-AMIDE DERIVATIVES USEFUL AS NEUTRAL ENDOPEPTIDASE AND ACE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-24 | — | — | WO | disclosed |
| EP-0595878-A1 | ACYLMERCAPTOALKANOYLDIPEPTIDES, METHODS OF PREPARATION AND THEIR THERAPEUTIC USE | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1994-05-11 | — | — | EP | disclosed |
| CN-1084849-A | Dual action inhibitors | SQUIBB & SONS INC (US) | 1994-04-06 | — | — | CN | disclosed |
| WO-1993002099-A1 | ACYLMERCAPTOALKANOYLDIPEPTIDES, METHODS OF PREPARATION AND THEIR THERAPEUTIC USE | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1993-02-04 | — | — | WO | disclosed |
| EP-0524553-A1 | Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1993-01-27 | — | — | EP | disclosed |
| CN-1061971-A | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and angiotensin converting enzyme | MERRELL DOW PHARMA (US) | 1992-06-17 | — | — | CN | disclosed |
| EP-0481522-A1 | Novel mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace | MERRELL PHARMACEUTICALS INC. (US) | 1992-04-22 | — | — | EP | disclosed |
| US-4513009-A | GLYCINE, ALANINE AND SERINE DERIVATIVES | SOCIETE CIVILE BIOPROJET (FR) | 1985-04-23 | — | — | US | disclosed |
| US-4513009-A | GLYCINE, ALANINE AND SERINE DERIVATIVES | SOCIETE CIVILE BIOPROJET (FR) | 1985-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010358-A1 | Production method of aromatic carboxylic acid derivative | AADAC, DDC, AADAT | ALPI 2302/4885PKM 3743/4885PTGS1 530/4885 |
| US-20100267788-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | AGTR1, REN, AGTR2 | ALPI 2831/4885PKM 3503/4885PTGS1 637/4885 |
| US-20050245764-A1 | Process for producing optically active 2-substituted carboxylic acid | CA2, UACA, ATIC | ALPI 2102/4885PKM 3891/4885PTGS1 1651/4885 |
| US-20030144546-A1 | Process for producing optically active carboxylic acid subtituted in 2-position | HAO2, CA2, HACL2 | ALPI 1743/4885PKM 3646/4885PTGS1 90/4885 |
| US-20020111512-A1 | Dynamic resolution of isomers and resolved isomers | DHCR24, LPAR1, SLC7A1 | ALPI 1764/4885PKM 4224/4885PTGS1 4158/4885 |
| US-20150011597-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | AGTR1, REN, AGTR2 | ALPI 2831/4885PKM 3503/4885PTGS1 637/4885 |
| US-20140046075-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | AGTR1, REN, AGTR2 | ALPI 2831/4885PKM 3503/4885PTGS1 637/4885 |
| US-20080188533-A1 | 2-Mercaptomethyl-4-methylpentanoic Acid (2-Butyryl-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]aminoethyl)amide | MME, AGTR1, AGTR2 | ALPI 2515/4885PKM 3811/4885PTGS1 1343/4885 |
| US-20060247470-A1 | Process for producing optically active carboxylic acid substituted in 2-position | HAO2, CA2, HACL2 | ALPI 969/4885PKM 3421/4885PTGS1 51/4885 |
| US-20040010039-A1 | Ethane-1,2-diaminium bis[(2R)-2-bromo-3-phenylpropanoate], processes for its preparation and its use | ACE, ECE1, ECE2 | ALPI 2674/4885PKM 1266/4885PTGS1 434/4885 |
| US-20120129900-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | AGTR1, REN, AGTR2 | ALPI 2831/4885PKM 3503/4885PTGS1 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.